Biotech · New York, United States
Serinus Biosciences
Serinus Biosciences is a seed-stage TechBio using a knowledge-primed AI engine to model cancer molecule function in tumor cells. Backed by Y Combinator and Illumina Ventures, its lead program targets a first-in-class PPI with a $20B US market.
Work at Serinus Biosciences?
- Location
- New York, United States
- Stage
- Seed
About Serinus Biosciences
Serinus Biosciences is an AI drug discovery company focused on cancer signaling. It aims to redefine precision in cancer therapeutics by modeling how molecules function inside tumor cells using a knowledge-primed AI engine. Founded by MIT PhDs, this seed-stage TechBio company is supported by Y-Combinator and backed by investors including Illumina Ventures, Vertex Ventures, Y-Combinator, and Merck Digital Science Studios. Its advisory board includes researchers from the Broad Institute, Dana-Farber Cancer Institute, and UCSD. The lead program targets a first-in-class PPI target with a US market opportunity of over $20 billion, and it has established multiple hit-series for previously undruggable PPI targets in under four months, with work published in Science, Cell, Nature Biotechnology, and Cancer Cell. It positions itself at the forefront of explainable AI for drug development and partners with leading pharma and biotech companies to accelerate treatments.
Company at a glance
The team at Serinus Biosciences
Location
Life at Serinus Biosciences
Frequently asked questions
Serinus Biosciences is based in New York, United States.
Ask your AI about Serinus Biosciences
Connect Clera once, then ask what they're hiring for.
Ask about this company
Tell me about Serinus Biosciences (https://www.getclera.com/companies/serinus-biosciences). Then find open roles at similar startups on Clera that fit my profile.
Not connected yet? Takes a minute
https://mcp.getclera.comSign in with your Clera account. MCP docs
Companies similar to Serinus Biosciences
We’re building the first autonomous insurance group, starting with Morrow, our AI-native commercial insurance brokerage. We help businesses find, compare, and buy insurance across 100+ carriers. Every placement deepens our understanding of businesses, risk, and underwriting. We’re turning that knowledge into an insurance ontology that gives our AI agents the context to reason, apply judgment, and execute insurance workflows autonomously across calls, emails, and carrier portals. Our ambition is to build the most comprehensive intelligence layer in the industry. Over time, we’ll use this foundation to develop and underwrite our own insurance products. Insurance spending represents 12% of U.S. GDP, and we want to go after all of it. We’re backed by C-suite executives at some of the world’s largest insurers, first-check investors in Rippling and Twilio, and a Cloudflare board member.
Alder is an AI-native property management company that operates directly in the property management industry. By leveraging artificial intelligence as a core part of its operations, Alder manages properties with a technology-forward approach designed to streamline and enhance traditional property management practices.
Aranya builds ClusterdOS, a GitOps-native distributed operating system that makes production-grade Kubernetes infrastructure accessible to solo developers and small teams. ClusterdOS removes operational barriers to Kubernetes adoption, and no platform team is required when using it. Aranya also offers managed Kubernetes services for bare metal deployments.